The lymphoid liver: Considerations on pathways to autoimmune injury

Gastroenterology

Volumn 120, Issue 6, 2001, Pages 1485-1501

  Kita, Hiroto ^a   Mackay, Ian R ^b   Van de Water, Judy ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOCHROME P450 2D6;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; DISEASE CLASSIFICATION; HUMAN; IMMUNE INJURY; IMMUNOLOGICAL TOLERANCE; LIVER INJURY; MOLECULAR MIMICRY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0035053878     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.22441     Document Type: Article

References (140)

1. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes
2. Natural T cells in the human liver: Cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24JalphaQ and gammadelta T cell receptor bearing cells
3. + natural T cells with distinct cytotoxic activities and Th1, Th2, and ThO cytokine secretion patterns
4. Isolation, phenotyping, and functional analysis of lymphocytes from human liver
5. - alpha beta T cells
6. - double negative T cells
7. An unusual lineage of alpha/beta T cells that contains autoreactive cells
8. - T alpha beta cells in the liver is a common feature of autoimmune mice
9. + intraepithelial T cell receptor alpha/beta + lymphocytes reveals a major extrathymic path-way of T cell differentiation
10. Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta
11. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases
12. Scavenger functions of the liver endothelial cell
13. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA- 3
14. Liver endocytosis and Kupffer cells
15. Molecular mechanisms of liver fibrogenesis: A homage to the role of activated fat-storing cells
16. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells
17. Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells
18. The immunobiology of bile and biliary epithelium
19. Extramedullary erythropoiesis in human liver grafts
20. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver
21. Immunolocalization of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver
22. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclcnal antibody OV-6
23. CD4 r cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium
24. Medullary thymic epithelium: A mosaic of epithelial "self"
25. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
26. Receptor editing in self-reactive bone marrow B cells
27. Homing of naive, memory and effector lymphocytes
28. Anergy as a mechanism of peripheral T cell tolerance
29. A theory of self-nonself discrimination
30. A new analysis of allogeneic interactions
31. CD40 and CD154 in cell-mediated immunity
32. CB28/B7 costimulation: A review
33. Antigen presentation by parenchymal cells: A route to peripheral tolerance?
34. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
35. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
36. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
37. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
38. Increased plasma interleukin-8 concentrations in alcoholic hepatitis
39. Cross-reactivity between streptococcus and human tissue: A model of molecular mimicry and autoimmunity
40. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure
41. Molecular mimicry: Can epitope mimicry induce autoimmune disease?
42. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1
43. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)
44. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
45. Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens
46. Reactivity of primary biliary cirrhosis sera with Escherichia coil dihydrolipoamide acetyltransferase (E2p): Characterization of the main immunogenic region
47. Autoantibodies in primary biliary cirrhosis: Analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes
48. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: Implications for molecular mimicry
49. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: Evidence of molecular mimicry in human autoimmune diseases
50. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis
51. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis
52. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2
53. Apoptosis: Molecular aspects of cell death and disease
54. Mitochondria and apoptosis
55. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
56. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations
57. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
58. Apoptosis and the pathogenesis of IDDM: A question of life and death
59. Apoptosis and thyroiditis
60. The role of chemokine receptors in primary, effector, and memory immune responses
61. Cytokines, chemokines, and their cognate receptors in autoimmune diseases
62. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1
63. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis
64. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E
65. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
66. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein i and macrophage inflammatory protein 1alpha in alcoholic liver disease
67. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
68. Inflammatory cytokines upregulate intercellular adhesion molecule-1 expression on primary cultured mouse hepatocytes and T-lymphocyte adhesion
69. Increased expression of intercellular adhesion molecule I on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis
70. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro
71. Immunogenicity of biliary epithelium: Study of the adhesive interaction with lymphocytes
72. Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58
73. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro
74. In situ hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset
75. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis
76. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis
77. Current understanding of eosinophil function
78. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
79. Effect of recombinant interleukin 5 on the generation of cytotoxic T cells (CTL)
80. + cytotoxic T cell (CTL) clones: Implications for CTL lytic mechanisms
81. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
82. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease
83. Autoimmune mechanisms in chronic hepatitis B and delta virus infections
84. + T cell receptor-alpha/beta+ cells: New clues to their origin, specificity, and function
85. TNF-alpha is a principal cytokine involved in the recruitment of NK cells to liver parenchyma
86. The role of Kupffer cells in the differentiation process of hepatic natural killer cells
87. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis
88. Apoptosis and hepatobiliary disease
89. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor super-family, in normal and neoplastic cells
90. Apoptosis: Bcl-2-related proteins get connected
91. Autoimmune reactivity of sera to hepatocyte plasma membrane in type I autoimmune hepatitis
92. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes
93. Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies
94. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: Comparison of different techniques
95. Liver/kidney microsomal antibody type i and liver cytosol antibody type i concentrations in type 2 autoimmune hepatitis
96. Argininosuccinate lyase: A new autoantigen ir liver disease
97. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis
98. Hepatocellular membrane antigens
99. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis
100. Limited usage of T-cell receptor beta chains and sequences of the complementarity determining region 3 of lymphocytes infiltrating in the liver of autoimmune hepatitis
101. T cell repertoire in the liver of patients with autoimmune hepatitis
102. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis
103. The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrat ng T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis
104. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro
105. Pathogenesis of autoimmune hepatitis
106. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis
107. A neonatally tolerant mouse model to assess pathogenicity of human autoantibodies
108. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis
109. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: A mouse model of primary biliary cirrhosis
110. Autoreactive cytotoxic T cells in mice are induced by immunization with a conserved mitochondrial enzyme in Freund's complete adjuvant
111. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice
112. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: Relationship of levels of autoantibodies to disease progression
113. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: An immunohistochemical study
114. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells
115. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis
116. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis
117. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis
118. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis
119. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex
120. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis
121. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis
122. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis
123. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis
124. Pathogenesis of primary biliary cirrhosis: CD95-induced apoptosis at last?
125. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset
126. Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis
127. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression
128. Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis
129. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
130. Recent developments in autoimmune liver diseases
131. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis
132. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: Do they react with different antigens?
133. Lymphocyte subsets in primary sclerosing cholangitis
134. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis
135. Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis
136. Phenotypic analysis of antigen-specific T lymphocytes
137. HLA-peptide tetrameric complexes
138. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen
139. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis
140. Structural requirements for antigen presentation by mouse CD1